Skip to main content

A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol

Abstract

Background

Virtual Learning Collaboratives (VLC), learning communities focused on a common purpose, are used frequently in healthcare settings to implement best practices. Yet, there is limited research testing the effectiveness of this approach compared to other implementation strategies. This study evaluates the effectiveness of a VLC compared to Technical Assistance (TA) among community oncology practices implementing ENABLE (Educate, Nurture, Advise, Before Life Ends), an evidence-based, early palliative care telehealth, psycho-educational intervention for patients with newly diagnosed advanced cancer and their caregivers.

Methods

Using Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) and Proctor’s Implementation Outcomes Frameworks, this two-arm hybrid type-III cluster-randomized controlled trial (RCT) will compare two implementation strategies, VLC versus TA, among the 48 National Cancer Institute Community Oncology Research Program (NCORP) practice clusters that have not historically provided palliative care to all patients with advanced cancer. Three cohorts of practice clusters will be randomized to the study arms. Each practice cluster will recruit 15–27 patients and a family caregiver to participate in ENABLE. The primary study outcome is ENABLE uptake (patient level), i.e., the proportion of eligible patients who complete the ENABLE program (receive a palliative care assessment and complete the six ENABLE sessions over 12 weeks). The secondary outcome is overall program implementation (practice cluster level), as measured by the General Organizational Index at baseline, 6, and 12 months. Exploratory aims assess patient and caregiver mood and quality of life outcomes at baseline, 12, and 24 weeks. Practice cluster randomization will seek to keep the proportion of rural practices, practice sizes, and minority patients seen within each practice balanced across the two study arms.

Discussion

This study will advance the field of implementation science by evaluating VLC effectiveness, a commonly used but understudied, implementation strategy. The study will advance the field of palliative care by building the capacity and infrastructure to implement an early palliative care program in community oncology practices.

Trial registration

Clinicaltrials.gov. NCT04062552; Pre-results. Registered: August 20, 2019. https://clinicaltrials.gov/ct2/show/NCT04062552?term=NCT04062552&draw=2&rank=1

Introduction

Background and rationale

Due to the benefits of early palliative care (EPC) in randomized controlled trials [1,2,3], the American Society of Clinical Oncology recommends “ … combined standard oncology care and palliative care … early in the course of illness for any patient with metastatic cancer and/or high symptom burden” [4] (p.881). Yet, the National Cancer Institute (NCI)’s “Landscape Study” revealed that only 30% of community oncology practices have access to palliative care multidisciplinary teams in outpatient settings [5, 6]. Even practices offering EPC are often unable to meet the needs of all advanced cancer patients due to a limited palliative care workforce and the large number of patients with advanced cancer and caregivers [7, 8]. Training existing oncology staff to provide evidence-based palliative care interventions [9] is a potentially scalable and sustainable approach to address the national shortage of palliative care specialists. The ENABLE (Educate, Nurture, Advise, Before Life Ends) program is an example of such an intervention that can be implemented by healthcare organizations seeking to develop or enhance palliative care services.

ENABLE is an evidence-based, scalable model of EPC promoted by the National Cancer Institute Evidence-Based Cancer Control Programs (EBCCP), formerly known as Research-Tested Intervention Program (RTIP) [10,11,12]. ENABLE is led by a Nurse Coach and includes a comprehensive palliative care assessment, weekly telehealth coaching sessions (6 for patient; 3 for caregiver) using the Charting Your Course© guidebook. The coaching sessions review essential palliative care topics, such as problem solving, coping, symptom management, self-care, communication, decision-making, and advance care planning and monthly follow-up calls (Fig. 1). The parallel ENABLE program topics for caregivers mirror the patient sessions. ENABLE has not been widely used in community oncology practices despite being publicly available through the EBCCP. An effective implementation strategy to address implementation barriers (e.g., lack of knowledge about evidence-based EPC, insufficient infrastructure) is needed to equip oncology practices to develop the skills to implement and sustain ENABLE. However, it is unclear which strategy would be most successful in assisting implementation.

Fig. 1
figure1

Charting your course (CYC) chapter/session topics

Two common strategies to enhance implementation of evidence-based practices include VLC and TA. VLC is an innovative version of the traditional (face-to-face) Learning Collaborative, developed by the Institute for Healthcare Improvement (IHI) to guide clinical teams in implementing evidence-based practices [13]. Learning collaboratives use group interaction among teams to guide clinical improvement efforts. VLC, which uses a virtual (web-based) platform instead of face-to-face meetings, was designed to decrease the cost of participation and increase the speed of incorporating lessons into practice [14, 15]. The evidence on VLCs appears to improve processes, but is inconclusive on outcomes [16, 17].

The second strategy, TA, is defined as “interactive support that is individualized to the specific needs of individuals or teams.” (p.3) [18]. TA is typically provided one-on-one to a single organization and does not use a community structure to encourage shared learning or collaboration [19]. The evidence on TA effectiveness is minimal [19, 20]. To our knowledge, there are few rigorous trials comparing the effectiveness of VLC or TA and more testing with rigorous study design is needed [14, 15, 21, 22]. Which strategy would be most effective for the widespread implementation of ENABLE in community oncology practices is unclear.

To address these gaps in implementation science and palliative care, we developed a cluster randomized controlled trial (RCT) that compares VLC to TA for implementing ENABLE in community oncology practices. Our primary hypothesis is that practices randomized to VLC will outperform those randomized to TA resulting in a higher proportion of patients completing the ENABLE program. The more effective implementation of ENABLE will be due to the benefits of group dynamics (e.g., shared experiences, accountability, learning, discussion, and interactions), and quality improvement learning/skills that occur in the VLC but not in TA. Ultimately, a greater uptake of ENABLE will lead to better outcomes (mood and quality of life) for the patients and caregivers at the practices exposed to VLC compared to those exposed to TA.

Study aims and hypotheses

Based on Proctor’s implementation framework, the purpose of this two-arm hybrid type-III cluster RCT in community oncology practices is to compare the effectiveness of two strategies, VLC and TA for implementing the evidence-based ENABLE program (Fig. 2).

Fig. 2
figure2

Adapted proctor’s implementation outcomes model applied to study aims

Primary aim (implementation outcome, patient level)

Compare the effectiveness of VLC vs. TA on ENABLE program uptake, as measured by the proportion of patients who complete the ENABLE program (i.e., have a palliative care assessment and complete the six ENABLE sessions). Hypothesis: Practice clusters randomized to VLC will have greater ENABLE program uptake than practice clusters randomized to TA.

Secondary aim (service outcome, practice level)

Compare the effectiveness of VLC vs. TA on practice clusters’ overall ENABLE program implementation. This will be assessed using the ENABLE General Organizational Index (GOI), which measures factors that influence institutional implementation of evidence-based practices. Hypothesis: Practice clusters randomized to VLC will have better overall ENABLE program implementation than practice clusters randomized to TA.

Exploratory aim 1 (patient & caregiver outcomes)

Compare practice clusters randomized to VLC or TA on patient and caregiver quality of life (QOL) and mood outcomes. Hypothesis: Patients and caregivers at practice clusters randomized to VLC will have better QOL and mood compared to those at practice clusters randomized to TA.

Exploratory aim 2

Determine the relationship among ENABLE program uptake, overall ENABLE program implementation, and patients’ QOL and mood across the two strategies. Hypothesis: Practice clusters with better ENABLE program uptake and overall ENABLE implementation (regardless of implementation group) will demonstrate a higher degree of improved patient outcomes (i.e., QOL and mood) compared to practice clusters that have low/poor ENABLE program uptake and overall ENABLE implementation.

Methods/design

Theoretical framework

This study is guided by the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework, which is designed to enhance the quality, speed, and public health impact of efforts to translate research into “real world” settings [23, 24]. Further, this study applies Proctor’s Implementation Outcomes framework [25] to assess implementation success via outcomes on three levels: implementation (effects of actions to implement new treatment), service (reflect the practice process changes), and client (evidence-based program’s effect on the target population).

Trial design

This two-arm hybrid type-III cluster RCT compares implementation strategy effectiveness, while gathering additional information on the ENABLE program outcomes [26,27,28]. VLC and TA have distinct communication channels, time requirements, social systems, and structures [29, 30]. A target sample of 48 NCI’s Community Oncology Research Program (NCORP) practices will be randomized to one of two conditions: 1) VLC group which will receive ENABLE training and participate in a 15-month VLC (n = 24) or 2) TA group which will receive ENABLE training and participate in a 15-month TA process (n = 24). Each NCORP practice in this study will be formed into “practice clusters.” Practice cluster is defined as an NCORP practice location where oncology physicians and study staff work independently and do not crossover to another practice. Practice clusters will be recruited in 3 cohorts of approximately 16 practice clusters per cohort. In each cohort half of the practice clusters will be randomized to VLC and half will be randomized to TA (Fig. 3).

Fig. 3
figure3

Trial design

Setting/sample

URCC NCORP practice cluster participation

This study is being carried out from the University of Rochester Cancer Center (URCC) NCORP Research Base. NCORP is a national network that brings cancer treatment and care delivery trials to people in community settings. NCORP is comprised of 7 Research Bases, and 46 Community Affiliates, each with affiliated practices [31]. The URCC NCORP Research Base is associated with 22 NCORPs and 358 sub-affiliates across the country. URCC NCORP practices vary in size and geographic location; however, to be eligible to participate in this study, they must meet the following inclusion criteria:

  • Identify two (or more) Nurse Coaches to deliver the ENABLE program. For practices that only have 1 nurse available, one Nurse Coach is allowed.

  • Commitment of Nurse Coaches to be trained to conduct the palliative care assessment and deliver the ENABLE sessions

  • Desire to implement ENABLE, including presence of an investigator (e.g., Primary Affiliate Principal Investigator, oncology physician, Cancer Care Delivery Research (CCDR) Lead) and/or program administrator/supervisor who are willing to be key contacts

  • Demonstrated support/buy-in from oncology physicians who are willing to enroll patients

  • Agreement of practice leadership and staff to support/participate in study activities

  • If necessary, willingness to participate in a phone interview to determine capacity to implement the ENABLE program.

Exclusion criteria

Practice clusters that currently offer fully functioning inter-professional early palliative care to all cancer patients will be excluded. If practices offer early palliative care services to some, but not to all cancer patients, practices will only enroll patients to this study who have not received early palliative care services.

Within practice cluster patients and caregivers participants

Patients

Patients will be encouraged (but not required) to select a caregiver, defined below, to participate in the study. Participants can receive cancer treatment while participating in the study but will not have received palliative care services at the time of enrollment.

Patient inclusion criteria

Patients must be diagnosed with advanced cancer (stage III/IV, recurrence, or progressive solid tumor cancer) within the last 90 days and have an expected survival of at least 6 months. Patients must be English-speaking, at least 18 years old, willing to complete the palliative care assessment and ENABLE sessions, have access to a telephone that can receive calls, and able to provide informed consent to participate in the study.

Patient exclusion criteria

Patients who received previous palliative care services will be excluded. However, after enrollment, patients may receive palliative care services outside of the ENABLE program, if appropriate.

Caregivers

Each patient can identify a single caregiver to participate in the study. The caregiver is any person who provides support to the patient. Caregivers may remain in the study even if the patient withdraws.

Caregiver inclusion criteria

Caregivers are defined as an “unpaid relative or friend who knows them well and who provides regular support to their cancer.” Caregivers must be English-speaking, at least 18 years old, willing to complete the ENABLE Caregiver program sessions, have access to a telephone that can receive calls, and able to provide informed consent to participate in the study.

Exclusion criteria

None.

Practice cluster recruitment

The URCC NCORP Research Base will announce the study via email to all URCC NCORP community affiliates and post study activation on the Cancer Trials Support Unit (CTSU) website. In addition, we will hold information webinars. Interested practice clusters will complete a form to describe the practice (e.g., current palliative care services, demographics of patient population, staff members to be involved in the study) and submit it to URCC Research Base. Each practice cluster will be expected to enroll and deliver ENABLE to 15–27 patients.

Patient and caregiver recruitment

Staff in each practice cluster will identify eligible patients from clinical schedules and inform oncology physicians. If the physician determines the patient to be eligible and the patient agrees to be informed about the study, study personnel at the practice (e.g., Nurse Coach, research coordinator) will meet the patient either in person or via HIPAA compliant phone or videoconference to review the study. Informed consent will be obtained either in person or using a HIPAA compliant phone or videoconference and documented.

Evidence-based practice to be implemented: ENABLE

The ENABLE program for patients consists of [1] a standardized in-person or telehealth Palliative Care Assessment [32] and [2] a series of six, 20–60 min weekly telephone coaching sessions provided by a Nurse Coach using the Charting Your Course© (CYC) guidebook [33, 34]. ENABLE fosters patient empowerment [35, 36] through coaching on problem-solving coping, symptom management, self-care, communication, decision-making, and life review and reflection. A Nurse Coach, who is a registered nurse or advanced practice provider (e.g., nurse practitioner or physician assistant) who has at least 2 years’ experience working in oncology or palliative care, delivers the ENABLE program. Caregivers receive a separate series of similar telephone sessions using a CYC© guidebook with caregiver-relevant content. After completing the weekly sessions, both the patient and caregiver receive monthly check-in phone calls. Figure 1 presents the CYC© session topics. Trials testing ENABLE have demonstrated improved patient quality of life, mood, and survival outcomes and reduced caregiver burden and improved mood [10, 11, 37].

Implementation interventions (practice cluster level)

Table 1 summarizes the essential elements of the VLC and TA implementation strategies and outlines the distinctive features between the two. Each practice cluster will assemble an implementation team who will participate in the assigned implementation strategy (VLC or TA). At minimum, this includes one or two Nurse Coaches who will deliver the intervention and at least one coordinator who will facilitate recruitment and patient and caregiver outcome assessment. Other members of the practice cluster (e.g., oncologists, data managers) are also encouraged to participate in implementation team and VLC or TA activities.

Table 1 Summary of Implementation Strategies

Virtual Learning Collaborative

Practice clusters randomized to the 15-month VLC will participate in monthly virtual group-based learning sessions to discuss key components of the ENABLE program, implementation progress (e.g., nurse coach training, number referrals, number patients/caregivers enrolled, sessions completed), data collection activities, and current successes and challenges. In addition, the VLC will include instruction on quality improvement tools and techniques to assist with the implementation process, coaching, and the opportunity to share stories and experiences and learn from other practice clusters using an “all teach, all learn” approach [13]. The VLC will be co-led by ENABLE and quality improvement experts (RT and KDL).

TA

Practice clusters randomized to the 15-month TA study arm will receive individual, interactive monthly consultation calls with an ENABLE expert (JND-O). The TA leader will ask similar questions about the practice cluster’s implementation progress as are covered in the VLC study arm (e.g., nurse training, referral process, enrollment, sessions completed, data collection activities, and current successes and challenges). The relationship between the TA provider (JND-O) and practice clusters will be friendly, trusting, strengths-based, collaborative, and will support practice cluster autonomy. We anticipate that practice clusters will solicit input or guidance from the TA leader on challenges or areas of concern. The TA leader will offer advice and suggestions to the degree desired by the practice cluster.

Study trainings

Nurse Coaches who deliver the ENABLE program will complete the approximately 19-h self-paced 10-module ENABLE training on a web-based platform (Canvas). The training, developed by ENABLE experts, consists of [1] an overview of the ENABLE program; [2] instruction on how to conduct the palliative care assessment and deliver each ENABLE session; [3] role play of the assessment and phone sessions that will be reviewed by an ENABLE expert who will provide feedback; and [4] tools and resources for Nurse Coaches. Upon completion of the ENABLE training, Nurse Coaches will complete an evaluation of the training to receive Continuing Education Unit (CEU) credits.

Additional trainings will cover study procedures and how to use the web-based study platforms: Canvas, Zoom, and Research Electronic Data Capture (REDCap), an electronic data capture tool to enter study data.

Measures and outcomes

Based on Proctor’s Framework (Table 2), this study has 3 categories of outcomes [1] implementation (aim 1), [2] service (aim 2), and [3] client (patient and caregiver) outcomes (exploratory aim 1).

Table 2 Measures and outcomes

Aim 1: ENABLE uptake (implementation outcome, patient level)

The primary outcome will be ENABLE program uptake (program completion). To capture ENABLE program uptake, each ENABLE Nurse Coach will use a standardized ENABLE Nurse Coach Contact Log to document patient and caregiver referrals, enrollment, and completion of the essential ENABLE elements (i.e., palliative care assessment, ENABLE sessions). The Nurse Coach Contact Log, which is completed in REDCap, will document each contact and ENABLE session using an assigned study identification for each patient or caregiver.

Aim 2: Overall ENABLE Program implementation (service outcome, practice cluster level)

This outcome will be measured for each practice cluster via phone interviews with Nurse Coaches and coordinators using the ENABLE General Organizational Index (GOI). This instrument was developed to assess factors that influence institutional implementation of the ENABLE program [38]. We previously adapted [38] the General Organizational Index (GOI) which measures fidelity to an evidence-based practice by assessing two key elements of implementation: individualization and quality improvement [64]. The GOI has been shown to have acceptable psychometric properties [39]. The ENABLE GOI structured interview guide covers 12 domains (program philosophy, eligibility/client identification, penetration, assessment, individualized initial palliative care treatment plan, individualized subsequent ENABLE contacts, supervision, process monitoring, outcome monitoring, quality assurance, and client choices regarding service provision) associated with successful implementation. ENABLE GOI assessments will occur at baseline, 6 months (± 8 weeks), and 1 year (± 8 weeks). After the phone interview, the interviewer [40] will score each domain on a Likert scale for a total range of 12–60. Moreover, interviews will be recorded and transcribed for qualitative analysis to augment quantitative assessment of this outcome.

Table 2 presents additional implementation measures, including RE-AIM, process outcomes for the study arms (VLC and TA), and ENABLE process measures.

Exploratory aim: patient measures

Table 2 presents patient measures. Patient assessments will be completed at baseline, 12, and 24 weeks. There will be several options to collect the data: [1] study coordinator reads the questions to the patient (either in person or on the phone) and enters the patient responses, [2] the patient completes the assessments in person with a study coordinator, or [3] the patient will take a paper copy home, complete it, and return it at either the next visit, via mail, or scan and email.

Exploratory aim: Caregiver measures

Caregiver assessments (Table 2) will be completed at baseline, 12 and 24 weeks using the same methods as for patients described above.

Sample size

Aim 1: Implementation outcome (patient level)

The RCT is powered for the aim 1 outcome, ENABLE program uptake, defined as the proportion of patients who complete the ENABLE program. In determining the targeted sample size, we made the following assumptions: [1] an intra-class correlation coefficient (ICC) value of 0.05, [2] alpha of 1% (α = 0.01) and 80% power, [3] 20% enrolled patients for whom completion of ENABLE cannot be assessed due to death or becoming too ill to continue with participation, and [4] a proportion of patients completing ENABLE of 0.52 in prior studies. With 24 practice clusters per group and a minimum of 12 patients per practice cluster (down from 15 after 20% unable to assess completion), for a total of 288 patients per group, the detectable difference in ENABLE program uptake is 0.18 (OR = 2.06; RR = 1.33), a medium effect size.

Randomization

This cluster-randomized trial will be carried out in 3 sequential cohorts of 8–20 practice clusters (4–10 per study arm) to reach the desired sample size of 48 practice clusters. Within each cohort, RCT arm assignment will occur after completion of all required study trainings, including the ENABLE training (Fig. 3). A minimization algorithm for group assignment with random initial start will be used to attempt to simultaneously balance the proportion of rural practices, practice sizes, and minority patients seen within each practice across the two RCT arms. The minimization algorithm will be generated using R software. Study team members and practice cluster members will not be blinded to group assignment or study hypotheses.

Statistical analysis

All randomized practice clusters will be included in primary comparisons, according to their group assignment, and regardless of their degree of participation in the study. Primary data analysis will include descriptive statistics for baseline practice cluster characteristics, patient characteristics, and outcomes in each RCT arm. We will examine the balance between RCT arms with respect to baseline characteristics (e.g., age, sex, race, cancer type, stage) using effect sizes, such Cohen’s d and Cramer’s. Factors showing non-trivial imbalances between comparators will be used as adjusting covariates in the between-group comparisons. Analysis will be conducted using the latest versions of SAS and R.

Analysis for aim 1: Implementation outcome (patient level)

We will use a logit GEE model with exchangeable correlation structure (to account for clustering within practice) for the binary patient uptake indictor (“yes” if the patient completed a palliative care assessment and all ENABLE program sessions prior to the 12 week assessments and “no” if the patient is still alive but has not completed a palliative care assessment and all six ENABLE program sessions prior to the 12-week assessments), with the group assignment as the main predictor. Model-predicted outcome proportions, odds ratios, relative risks, and confidence intervals for these measures will be used for interpretation. Supplemental analyses using appropriate methods for clustered data will consist of between-group comparisons of the proportion of recruited patients who could not complete the ENABLE sessions due to illness or death, and the number of sessions completed among all patients recruited.

Analysis for aim 2: Service outcome (practice cluster level)

Analysis will compare VLC vs. TA on NCORP practices’ overall ENABLE program implementation measured by the ENABLE GOI. Due to the small sample size for this practice cluster-level outcome (24 VLC vs. 24 TA), rather than conducting formal inference testing, comparisons will be descriptive statistics and effect size measures.

Qualitative analysis

The audio-recorded interviews of the ENABLE GOI will be coded by study team members (EC-S) [40] in Atlas.ti using a qualitative content analysis approach using a priori domains from the GOI measure and additional categories that emerge from the inductive review of transcripts [65]. Coded data will be aggregated and reviewed within and across codes to construct an in-depth understanding of facilitators, barriers, and contextual factors that may influence implementation of the ENABLE program.

Findings from the qualitative data will be integrated with the main findings of the RCT at the interpretation and reporting stage [66]. We will use a convergent mixed methods analysis to collect both qualitative and quantitative ENABLE GOI data at roughly the same time, assess information using parallel constructs for both types of data, separately analyze both types of data, and then compare results through discussion and jointly displaying both forms of data. The joint display will map each ENABLE GOI domain score to corresponding concepts or themes from these qualitative findings to more fully understand the context of the GOI domain scores and identify patterns across practice clusters [67]. This will provide validation for each data type and create a foundation for drawing conclusions about the implementation of the ENABLE program [68].

Analysis for exploratory aims (patient and caregiver outcomes)

Exploratory aim 1

To compare NCORP practices randomized to VLC or TA on patient and caregiver quality of life and mood, linear mixed models will be used to estimate differences in patient and caregiver outcome trajectories over the 24-week follow-up period. If necessary, a false discovery rate adjustment will be used to adjust for multiple exploratory inferences [69].

Exploratory aim 2

The association between ENABLE sessions and change in patient outcomes will be examined with linear mixed models. Adjusting covariates will include patient characteristics that may influence participation in sessions (e.g., sex, illness acuity, age). Linear mixed models will also be used to examine the association between GOI scores and patient outcomes.

Discussion

The relative strengths of learning collaboratives compared to other implementation strategies are poorly understood [16, 17]. This study will provide a direct comparison between the VLC and TA strategies to determine if VLC is a superior method to facilitate implementation of the evidence-based ENABLE program in community-based oncology practices. Finding successful strategies to implement models of early palliative care in cancer is imperative given national guidelines that have highlighted this priority [70].

Most published studies on VLCs are descriptive and have not definitively tested its effectiveness to enhance adoption and implementation [16, 71,72,73,74,75,76,77,78,79,80,81,82]. There are also few randomized-clinical trials that evaluate traditional in-person learning collaboratives [14, 15, 21, 22] or compare their effectiveness to other implementation approaches [16, 17, 71, 83]. For example, learning collaboratives have been shown to outperform financial incentives or toolkits, but only on some process or secondary outcomes [16, 17]. This study will contribute to the fields of implementation science and palliative care as we will learn about the implementation effectiveness of VLC and TA while delivering an evidence-based practice. While we hypothesize the VLC will outperform TA due to the shared wisdom generated by the group, the VLC strategy has greater demands for sites and facilitators (and possibly costs) and has less opportinuity for individual attention than TA. As such, it is important to assess the added value of each strategy in order to know how to better spread and sustain EPC. Therefore, this study will inform efforts to more widely disseminate ENABLE, while simultaneously advancing implementation science methods and approaches that can be used for other evidence-based practices.

Like most research, we have encountered challenges during the study start-up period. First, the COVID-19 pandemic significantly impacted the ability for NCORP practices to conduct research and resulted in a need to rely on telehealth. Although most ENABLE activities were already offered via telephone, we modified the protocol so that all study procedures can now be conducted remotely, including the consent process and the comprehensive palliative care assessment. During this time, NCORP practices also expressed concern about the time required to complete the Nurse Coach training. To reduce training burden, the length of the web-based ENABLE Nurse Coach training was reduced from 25 h to approximately 19 h. We anticipate the reduced number of training hours may be beneficial beyond the study given our goal to make the ENABLE training more broadly scalable to nurses and advanced practice providers interested in implementing this EPC program. We also amended the originally required cohort size (n = 16) and will permit cohorts of 8–20 practice clusters (4–10 per study arm). To account for this in analyses, we will assess for confounding by cohort. Lastly, although each practice cluster will be expected to deliver ENABLE to 15–27 patients, we recognize that may not happen. To account for this, we will include an option to recruit additional practice clusters (up to 20% of 48 which is 58 practices) and additional cohorts. Despite these challenges, we anticipate the first cohort will launch in the first half of 2021.

There are several anticipated lessons learned from this study. First, to the best of our knowledge, this is the first large-scale study measuring the implementation of early palliative care in community-based oncology practices. To measure implementation, we developed and refined palliative care implementation measures and anticipate that lessons learned will be used to improve these measures. Second, this study not only seeks to identify the superior implementation strategy (VLC or TA), but also to examine the key components of each strategy. To do so, we have developed measures of participation, engagement, and fidelity that have not been applied in other published literature. Lessons learned will inform refinement of the measures and advance the field.

Strengths and limitations

There are several strengths to this study. First, this study will evaluate both the uptake of an evidence-based EPC intervention and organizational factors associated with improving delivery of EPC in community based care. Second is the collaboration with the URCC NCORP. Conducting this work outside a consortium would be difficult, particularly with respect to recruiting practice clusters. Third, this study provides a solution to the limited palliative care workforce by implementing this program as a generalist palliative care model [84]. As part of study activities, Nurse Coaches will be trained on how to deliver the ENABLE EPC program, thereby increasing practice capacity to offer palliative care services [7, 8, 85]. A final, yet unanticipated strength to this study is the opportunity to implement the effective ENABLE EPC telehealth model in community oncology clinics during COVID-19 when telehealth services are particularly important.

While this study will contribute to implementation science methods and approaches, there are limitations. Patients and caregivers will not know which study arm their practice cluster is assigned. However, practice clusters will not be blinded to study aims and hypotheses as sharing those are essential to study recruitment and consent procedures. Similarly, blinding the TA and VLC facilitators and the assessors (e.g., ENABLE GOI interviewer) to the group assignment is not feasible. However, it is feasible to limit their knowledge of specific activities in each study arm to minimize bias. Contamination between practice cluster cohorts is another potential limitation. Since all practice clusters will be affiliated with URCC NCORP, enrolled practice clusters may discuss their study involvement with practices that register for a future cohort. To minimize potential contamination between cohorts, we will instruct second and third cohorts to reach out to the TA or VLC members (depending on randomization assignment) as opposed to outside practices for advice.

Conclusion

The results from this study will be twofold: [1] we will learn about the implementation of an early palliative care intervention among community oncology practices, and [2] we will learn about the effectiveness of the VLC as compared to TA to facilitate such implementation. In addition, lessons learned will advance the field of implementation science through further refinement of palliative care implementation measures and of the VLC implementation strategy.

Availability of data and materials

The investigators will provide access to data according to NIH and University of Rochester NCI Community Oncology Research Program policies.

Abbreviations

ACS:

American Cancer Society

CCDR:

Cancer Care Delivery Research

CCM:

Chronic Care Model

CIC:

Chronic Illness Care

CIRB:

Central Institutional Review Board

CONSORT:

Consolidated standards of reporting trials

CYC:

Charting Your Course

DSMC:

Data Safety Monitoring Committee

EBP:

Evidence-based practice

ENABLE:

Educate, Nurture, Advise, Before Life Ends

EPC:

Early Palliative Care

ERIC:

Expert Recommendations for Implementing Change

FACT-G:

Functional Assessment of Cancer Therapy–General

FACIT-PAL:

Functional Assessment of Chronic Illness-Palliative Care

GOI:

General Organizational Index

HADS:

Hospital Anxiety and Depression Scale

ICC:

Intra-class Correlation Coefficient

LC:

Learning Collaborative

BMCB:

Montgomery Borgatta Caregiver Burden Scale

MDASI:

MD Anderson Symptom Inventory

NCI:

National Cancer Institute

NCORP:

NCI Community Oncology Research program

PI:

Principal investigator

PROMIS:

Patient Reported Outcome Measurement Information System

QOL:

Quality of life

RCT:

Randomized controlled trial

RE-AIM:

Reach, Effectiveness, Adoption, Implementation, Maintenance Framework

REDCap:

Research Electronic Data Capture

RUCA:

Rural-Urban Commuting Area

TA:

Technical Assistance

UAB:

University of Alabama at Birmingham

UR:

University of Rochester

URCC:

University of Rochester Cancer Center

VLC:

Virtual Learning Collaborative

References

  1. 1.

    Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316(20):2104–14.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Meneses K, Landier W, Dionne-Odom JN. Vulnerable population challenges in the transformation of cancer care. Semin Oncol Nurs. 2016;32(2):144–53.

    PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Hoerger M, Wayser GR, Schwing G, Suzuki A, Perry LM. Impact of interdisciplinary outpatient specialty palliative care on survial and quality of life in adults with advanced cancer: a meta-analysis of randomized controlled trials. Ann Behav Med. 2018;53(7):674–85.

    PubMed Central  Article  Google Scholar 

  4. 4.

    Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880–7.

    PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Carlos RC, Sicks JD, Chang GJ, Lyss AP, Stewart TL, Sung L, et al. Capacity for cancer care delivery research in National Cancer Institute Community Oncology Research Program Community Practices: availability of radiology and primary care research partners. J Am Coll Radiol. 2017;14(12):1530–7.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Kent EE, Mitchell SA, Castro KM, DeWalt DA, Kaluzny AD, Hautala JA, et al. Cancer care delivery research: building the evidence base to support practice change in community oncology. J Clin Oncol. 2015;33(24):2705–11.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Kamal AH, Wolf SP, Troy J, Leff V, Dahlin C, Rotella JD, et al. Policy changes key to promoting sustainability and growth of the specialty palliative care workforce. Health Aff (Millwood). 2019;38(6):910–8.

    PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    Lupu D, Quigley L, Mehfoud N, Salsberg ES. The growing demand for hospice and palliative medicine physicians: will the supply keep up? J Pain Symptom Manage. 2018;55(4):1216–23.

    PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Hui D, Bruera E. Models of palliative care delivery for patients with cancer. J Clin Oncol. 2020;38(9):852–65.

    PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438–45.

    PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1446–52.

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    The breakthrough series: IHI’s collaborative model for achieving breakthrough improvement. Boston, MA; 2003.

  14. 14.

    Nadeem E, Olin SS, Hill LC, Hoagwood KE, Horwitz SM. Understanding the components of quality improvement collaboratives: a systematic literature review. Milbank Q. 2013;91(2):354–94.

    PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Schouten LM, Hulscher ME, van Everdingen JJ, Huijsman R, Grol RP. Evidence for the impact of quality improvement collaboratives: systematic review. BMJ. 2008;336(7659):1491–4.

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Fu LY, Zook K, Gingold JA, Gillespie CW, Briccetti C, Cora-Bramble D, et al. Strategies for improving vaccine delivery: a cluster-randomized trial. Pediatrics. 2016;137(6).

  17. 17.

    Speroff T, Ely EW, Greevy R, Weinger MB, Talbot TR, Wall RJ, et al. Quality improvement projects targeting health care-associated infections: comparing virtual collaborative and toolkit approaches. J Hosp Med. 2011;6(5):271–8.

    PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Leeman J, Calancie L, Hartman MA, Escoffery CT, Herrmann AK, Tague LE, et al. What strategies are used to build practitioners' capacity to implement community-based interventions and are they effective?: a systematic review. Implement Sci. 2015;10:80.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Chilenski SM, Perkins DF, Olson J, Hoffman L, Feinberg ME, Greenberg M, et al. The power of a collaborative relationship between technical assistance providers and community prevention teams: a correlational and longitudinal study. Eval Program Plann. 2016;54:19–29.

    PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Katz J, A W. Technical assistance to enhance prevention capacity: a research synthesis of the evidence base. Prev Sci. 2016;17(4):417–28.

    PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Hulscher ME, Schouten LM, Grol RP, Buchan H. Determinants of success of quality improvement collaboratives: what does the literature show? BMJ Qual Saf. 2013;22(1):19–31.

    PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Nadeem E, Olin S, Hill L, Hoagwood K, Horwitz S. A literature review of learning collaboratives in mental health care: used but untested. Psychiatr Serv. 2014;65(9):1088–99.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    What is RE-AIM? 2016 [Available from: http://www.re-aim.org.

  24. 24.

    Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44(2):119–27.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  25. 25.

    Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.

    PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.

    PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Damschroder LJ, Moin T, Datta SK, Reardon CM, Steinle N, Weinreb J, et al. Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial. Implement Sci. 2015;10:68.

    PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Smelson DA, Chinman M, McCarthy S, Hannah G, Sawh L, Glickman M. A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs. Implement Sci. 2015;10:79.

    PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Dearing JW, Kreuter MW. Designing for diffusion: how can we increase uptake of cancer communication innovations? Patient Educ Couns. 2010;81(Suppl):S100–10.

    PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Rogers EM. Diffusion of innovations. Fifth Edition ed. New York: Free Press; 2003.

    Google Scholar 

  31. 31.

    National Cancer Institute. Community Oncology Research Program. US: Department of Health and Human Services; 2020. [Available from: https://ncorp.cancer.gov/about/.

  32. 32.

    Manca DP, Aubrey-Bassler K, Kandola K, Aguilar C, Campbell-Scherer D, Sopcak N, et al. Implementing and evaluating a program to facilitate chronic disease prevention and screening in primary care: a mixed methods program evaluation. Implement Sci. 2014;9:135.

    PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64–78.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Wasson JH, Splaine ME, Bazos D, Fisher ES. Overview: working inside, outside, and side by side to improve the quality of health care. Jt Comm J Qual Improv. 1998;24(10):513–7.

    CAS  PubMed  Google Scholar 

  35. 35.

    McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, et al. Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50–62.

    PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Dionne-Odom JN, Kono A, Frost J, Jackson L, Ellis D, Ahmed A, et al. Translating and testing the ENABLE: CHF-PC concurrent palliative care model for older adults with heart failure and their family caregivers. J Palliat Med. 2014;17(9):995–1004.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Bakitas M, Lyons KD, Hegel MT, Balan S, Barnett KN, Brokaw FC, et al. The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat Support Care. 2009;7(1):75–86.

    PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Zubkoff L, Dionne-Odom JN, Pisu M, Babu D, Akyar I, Smith T, et al. Developing a “toolkit” to measure implementation of concurrent palliative care in rural community cancer centers. Palliat Support Care. 2017:1–13.

  39. 39.

    Heiervang KS, Egeland KM, Landers M, Ruud T, Joa I, Drake RE, et al. Psychometric properties of the general organizational index (GOI): a measure of individualization and quality improvement to complement program fidelity. Adm Policy Ment Health. 2020.

  40. 40.

    Freund T, Wensing M, Mahler C, Gensichen J, Erler A, Beyer M, et al. Development of a primary care-based complex care management intervention for chronically ill patients at high risk for hospitalization: a study protocol. Implementation Science. 2010;5(1):70.

    PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Babu D, Dionne-Odom JN, Smith T, Zubkoff L, Bakitas M. Oncology providers’ perceptions of early/concurrent palliative care. In: Annual Assembly of the Americal Academy of Hospice and Palliative Medicine and the Hospice and Palliative Nurses Association. Chicago: IL; 2016.

    Google Scholar 

  42. 42.

    Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.

    PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Clark A, Fallowfield LJ. Quality of life measurements in patients with malignant disease: a review. J R Soc Med. 1986;79(3):165–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Herrmann C. International experiences with the hospital anxiety and depression scale--a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17–41.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  45. 45.

    McMillan SC, Small BJ, Weitzner M, Schonwetter R, Tittle M, Moody L, et al. Impact of coping skills intervention with family caregivers of hospice patients with cancer: a randomized clinical trial. Cancer. 2006;106(1):214–22.

    PubMed  Article  PubMed Central  Google Scholar 

  46. 46.

    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Brady MJ, Cella D. Assessing quality of life in palliative care. Cancer Treat Res. 1999;100:203–16.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997;15(3):974–86.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Lyons KD, Bakitas M, Hegel MT, Hanscom B, Hull J, Ahles TA. Reliability and validity of the functional assessment of chronic illness therapy-palliative care (FACIT-Pal) scale. J Pain Symptom Manage. 2009;37(1):23–32.

    PubMed  Article  PubMed Central  Google Scholar 

  50. 50.

    Facit.org. Functional Assessment of Chronic Illness Therapy- Palliative Care. 2020. [Available from https://www.facit.org/measures/FACIT-Pal]. Accessed 22 Feb 2020.

  51. 51.

    Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179–94.

    PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873–80.

    PubMed  PubMed Central  Article  Google Scholar 

  53. 53.

    HealthMeasures. Obtain & Administer Measures: Northwestern University; 2018 [Available from: http://www.healthmeasures.net/explore-measurement-systems/promis/obtain-administer-measures.

  54. 54.

    HealthMeasures. Global Health: Northwestern University; 2018 [Available from: http://www.healthmeasures.net/administrator/components/com_instruments/uploads/PROMIS Global Scoring Manual.pdf.

  55. 55.

    Center MAC. The MD Anderson Symptom Inventory: University of Texas; 2018 [Available from: https://www.mdanderson.org/research/departments-labs-institutes/departments-divisions/symptom-research/symptom-assessment-tools/md-anderson-symptom-inventory.html.

  56. 56.

    Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  57. 57.

    Montgomery R. Using and interpreting the montgomery borgatta caregiver burden scale 2016 [Available from: https://www.researchgate.net/profile/Rhonda_Montgomery2/publication/265679222_Using_and_Interpreting_the_Montgomery_Borgatta_Caregiving_Burden_Scale/links/56aac20508aed5a01358c5bd.pdf?origin=publication_list.

  58. 58.

    Montgomery R, Borgatta E, Borgatta M. Societal and family change in the burden of care. In: Liu W, Kendig H, editors. Who Should Care for the Elderly? Singapore: Singapore University Press; 2000. p. 27–54.

    Google Scholar 

  59. 59.

    O'Hara RE, Hull JG, Lyons KD, Bakitas M, Hegel MT, Li Z, et al. Impact on caregiver burden of a patient-focused palliative care intervention for patients with advanced cancer. Palliat Support Care. 2010;8(4):395–404.

    PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Tarlow BJ, Wisniewski SR, Belle SH, Rupert M, Ory MG, Gallagher-Thompson D. Positive aspects of caregiving: contributions of the REACH project to the development of new measures for alzheimer's caregiving. Research on Aging. 2004;26(4):429–53.

    Article  Google Scholar 

  61. 61.

    Archbold PG, Stewart BJ, Greenlick MR, Harvath T. Mutuality and preparedness as predictors of caregiver role strain. Res Nurs Health. 1990;13(6):375–84.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Carter JH, Stewart BJ, Archbold PG, Inoue I, Jaglin J, Lannon M, et al. Living with a person who has Parkinson’s disease: the spouse’s perspective by stage of disease. Parkinson’s Study Group. Mov Disord. 1998;13(1):20–8.

    CAS  Google Scholar 

  63. 63.

    Zwicker D. Preparedness for Caregiving Scale. New York: New York University, College of Nursing; 2010.

    Google Scholar 

  64. 64.

    McHugo GJ, Drake RE, Whitley R, Bond GR, Campbell K, Rapp CA, et al. Fidelity outcomes in the National Implementing Evidence-Based Practices Project. Psyciatr Serv. 2007;58(10):1279–84.

    Article  Google Scholar 

  65. 65.

    Brooks J, McCluskey S, Turley E, King N. The utility of template analysis in qualitative psychology research. Qual Res Psychol. 2015;12(2):202–22.

    PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48(6 Pt 2):2134–56.

    PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Guetterman TC, Fetters MD, Creswell JW. Integrating quantitative and qualitative results in health science mixed methods research through joint displays. Ann Fam Med. 2015;13(6):554–61.

    PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Wisdom J, Creswell JW. Mixed methods: integrating quantitative and qualitative data collection and analysis while studying patient-centered medical home models. Rockville, MD; 2013 February 2013. Report No.: 13-0028-EF.

  69. 69.

    Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67(8):850–7.

    PubMed  Article  PubMed Central  Google Scholar 

  70. 70.

    Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96–112.

    PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Boushon B, Provost L, Gagnon J, Carver P. Using a virtual breakthrough series collaborative to improve access in primary care. Jt Comm J Qual Patient Saf. 2006;32(10):573–84.

    PubMed  PubMed Central  Google Scholar 

  72. 72.

    Butler A, Canamucio A, Macpherson D, Skoko J, True G. Primary care staff perspectives on a virtual learning collaborative to support medical home implementation. J Gen Intern Med. 2014;29(Suppl 2):S579–88.

    PubMed  Article  PubMed Central  Google Scholar 

  73. 73.

    Cranley LA, Norton PG, Cummings GG, Barnard D, Estabrooks CA. SCOPE: safer care for older persons (in residential) environments: a study protocol. Implement Sci. 2011;6:71.

    PubMed  PubMed Central  Article  Google Scholar 

  74. 74.

    Gance-Cleveland B, Aldrich H, Dandreaux D, Oetzel KB, Schmiege S. A virtual childhood obesity collaborative: satisfaction with online continuing education. J Pediatr Health Care. 2015;29(5):413–23.

    PubMed  Article  PubMed Central  Google Scholar 

  75. 75.

    Gance-Cleveland B, Aldrich H, Schmiege S, Tyler K. Virtual obesity collaborative with and without decision-support technology. Int J Qual Health Care. 2016;28(3):316–23.

    PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Gingold JA, Briccetti C, Zook K, Gillespie CW, Gubernick RS, Moon RY, et al. Context matters: practitioner perspectives on immunization delivery quality improvement efforts. Clin Pediatr (Phila). 2016;55(9):825–37.

    PubMed  Article  PubMed Central  Google Scholar 

  77. 77.

    John T, Morton M, Weissman M, O'Brien E, Hamburger E, Hancock Y, et al. Feasibility of a virtual learning collaborative to implement an obesity QI project in 29 pediatric practices. Int J Qual Health Care. 2014;26(2):205–13.

    PubMed  Article  PubMed Central  Google Scholar 

  78. 78.

    McHugh MC, Margolis LH, Rosenberg A, Humphreys E. Advancing MCH interdisciplinary/interprofessional leadership training and practice through a learning collaborative. Matern Child Health J. 2016;20(11):2247–53.

    PubMed  Article  PubMed Central  Google Scholar 

  79. 79.

    Zubkoff L, Neily J, Mills PD, Borzecki A, Shin M, Lynn MM, Gunnar W, Rosen A. Using a virtual breakthrough series collaborative to reduce postoperative respiratory failure in 16 Veterans Health Administration hospitals. Jt Comm J Qual Patient Saf. 2014;40(1):11–20.

  80. 80.

    Zubkoff L, Neily J, King B, Dellefield ME, Krein S, Young-Xu Y, Boar S, Mills PD. Virtual breakthrough series, part 1: preventing catheter-associated urinary tract infection and hospital-acquired pressure ulcers in the veterans health administration. Jt Comm J Qual Patient Saf. 2016;42(11):485–98.

  81. 81.

    Zubkoff L, Neily J, Quigley P, Soncrant C, Young-Xu Y, Boar S, Mills PD. Virtual breakthrough series, part 2: improving fall prevention practices in the veterans health administration. Jt Comm J Qual Patient Saf. 2016;42(11):497–517.

  82. 82.

    Zubkoff L, Neily J, King B, Morgan S, Young-Xu Y, Boar S, Mills PD. Preventing pressure ulcers in the VHA using a virtual breakthrough series. J Nurs Care Qual. 2016;32(4):301–8.

  83. 83.

    Aschbrenner K.A., Pratt S.I., Bond GR., Zubkoff L, Naslund J.A., Jue K, et al. A virtual learning collaborative to implement health promotion in routine mental health settings: protocol for a cluster randomized trial. Contemp Clin Trials. 2019;84(105816).

  84. 84.

    Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Eng J Med. 2013;368(23465068):1173–5.

    CAS  Article  Google Scholar 

  85. 85.

    Lupu D. American Academy of Hospice and Palliative Medicine Workforce Task Force. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage. 2010;40(6):899–911.

Download references

Acknowledgements

The research reported in this protocol uses resources of the Dartmouth Hitchcock Medical Center, Dartmouth College, The Norris Cotton Cancer Center, University of Alabama, at Birmingham, University of Rochester, University of Rochester Cancer Center, and University of Rochester Cancer Center NCORP Research Base. Some work for this manuscript was conducted while Dr. Zubkoff was affiliated with the Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, and the White River Junction VA Medical Center.

Trial status

The study is actively recruiting practices for cohort 1.

Protocol amendments

Protocol amendments are reviewed and approved by NCI CIRB.

Informed consent

Current, state, federal, and institutional regulations concerning informed consent will be followed. Patients must have capacity to sign an informed consent. Consent documents will be signed by patients and caregivers; copies of the signed documents will be provided to the participants. A waiver of documentation of consent will be used for oncology physicians, ENABLE Nurse Coaches, Coordinators, and Other NCORP staff (e.g., Primary Affiliate PIs, CCDR lead, administrators/supervisors).

Confidentiality

All written materials will be kept confidential, locked in the private offices, and limited-access file room of the URCC NCORP Research Base and identified by ID numbers. All electronic information will be kept confidential with password-protected, limited access.

Access to data

Per protocol, all study data will be retained by the URCC NCORP Research Base for 5 years after completion of the study. Designated research personnel, including those at Dartmouth and UAB, is granted access to the data stored in the REDCap and Access databases. After completion of the study and publication of the study results, the de-identified study data will be available on the NCTN/NCORP Data Archive.

Data and safety monitoring plan

The James P Wilmot Cancer Center Data Safety Monitoring Committee (DSMC) will serve as the DSMC of record for this study. The DSMC provides oversight of study progress and safety by review of accrual and events at regularly scheduled meetings. The DSMC will monitor all adverse event rates. DSMC reports will be available for download on the Research Base website.

Provenance and peer review

Not commissioned; peer-reviewed for ethical and funding approval prior to submission.

Disclaimer

The funder did not have a role in the design or conduct of the study, and the authors have ultimate authority over study activities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute.

Funding

Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R01CA229197. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of health.

Author information

Affiliations

Authors

Contributions

LZ, MAB, and SM conceived the study and LZ, MAB, SM, JND-O, AA, MP, MF, and KL contributed to the study design. LZ, KL, JND-O, GH, MP, AA, MF, RT, EC-S, SM, and MAB drafted the manuscript, and all authors provided comments and feedback for improvement the manuscript. All authors approved the final version of the manuscript and are responsible for their contributions.

Corresponding author

Correspondence to Lisa Zubkoff.

Ethics declarations

Ethics approval and consent to participate

This study, URCC18110CD, was reviewed and approved by the NCI Central Institutional Review Board (CIRB). Original approval was received on July 2, 2019. Subsequent amendments were approved on October 11, 2019, September 3, 2020, and October 21, 2020. NCI CIRB acts as the single IRB of record for all study sites. The protocol is registered at ClinicalTrials.gov (NCT04062552).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zubkoff, L., Lyons, K.D., Dionne-Odom, J.N. et al. A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol. Implementation Sci 16, 25 (2021). https://doi.org/10.1186/s13012-021-01086-3

Download citation

Keywords

  • Implementation strategies
  • Implementation science
  • Early palliative care
  • Advanced cancer
  • Cluster-randomized controlled trial
\